Zobrazeno 1 - 3
of 3
pro vyhledávání: '"JF Sierra-Sanchez"'
Autor:
A Varas-Perez, R Gavira-Moreno, V Sanchez-Piazza, JF Sierra-Sanchez, C Puivecino Moreno, R Gazquez-Perez, A Alcala Soto
Publikováno v:
Section 2: Selection, Procurement and Distribution.
Background A Therapeutic Positioning Report published by the Spanish Agency for Medicines and Healthcare Products concludes that there are no differences in efficacy and safety between nivolumab, pembrolizumab and atezolizumab for patients with lung
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a72c1823769c7fd717ef02a2e6fb690a
https://doi.org/10.1136/ejhpharm-2019-eahpconf.47
https://doi.org/10.1136/ejhpharm-2019-eahpconf.47
Publikováno v:
Eur J Hosp Pharm
BackgroundImproving the quality of drug prescriptions is part of the corporate objectives of health systems. Finding the correlation between the quality of the prescription measured through a synthetic quality indicator (SIQ) and the prevalence of po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf835d743769d2ea1633441aa9037a1e
https://doi.org/10.1136/ejhpharm-2018-eahpconf.463
https://doi.org/10.1136/ejhpharm-2018-eahpconf.463
Autor:
Gil-Sierra MD; Hospital Universitario Puerto Real, Puerto Real, Spain., Briceño-Casado MP; Hospital Universitario de Jerez de la Frontera, Jerez de la Frontera, Spain pilarbricenocasado@gmail.com., Sierra-Sanchez JF; Hospital Universitario de Jerez de la Frontera, Jerez de la Frontera, Spain pilarbricenocasado@gmail.com.
Publikováno v:
The New England journal of medicine [N Engl J Med] 2022 Jun 30; Vol. 386 (26), pp. 2535-2536.